Managing low-level HIV viraemia in antiretroviral therapy: a systematic review and meta-analysis.

Autor: Zaçe D; Infectious Disease Clinic, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy., Rindi LV; Infectious Disease Clinic, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy., Compagno M; Infectious Disease Clinic, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy., Colagrossi L; Microbiology and Diagnostic Immunology, Bambino Gesu Paediatric Hospital, Roma, Italy., Santoro MM; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy., Andreoni M; Infectious Disease Clinic, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy., Perno CF; Microbiology and Diagnostic Immunology, Bambino Gesu Paediatric Hospital, Roma, Italy.; UniCamillus, Rome, Italy., Sarmati L; Infectious Disease Clinic, Department of Systems Medicine, University of Rome Tor Vergata, Roma, Italy srmldn00@uniroma2.it.

Publikováno v: Sexually transmitted infections [Sex Transm Infect] 2024 Oct 17; Vol. 100 (7), pp. 460-468. Date of Electronic Publication: 2024 Oct 17.

Histoplasmosis in patients living with HIV in Europe: review of literature.

Autor: Kontogiannis D; Department of Systems Medicine, Infectious Disease Clinic, Tor Vergata University, Rome, Italy., Di Lorenzo A; Department of Systems Medicine, Infectious Disease Clinic, Tor Vergata University, Rome, Italy., Zaçe D; Department of Systems Medicine, Infectious Disease Clinic, Tor Vergata University, Rome, Italy., Benvenuto D; Department of Systems Medicine, Infectious Disease Clinic, Tor Vergata University, Rome, Italy., Moccione M; Department of Systems Medicine, Infectious Disease Clinic, Tor Vergata University, Rome, Italy., Muratore G; Department of Systems Medicine, Infectious Disease Clinic, Tor Vergata University, Rome, Italy., Giacalone ML; Department of Systems Medicine, Infectious Disease Clinic, Tor Vergata University, Rome, Italy., Montagnari G; Department of Systems Medicine, Infectious Disease Clinic, Tor Vergata University, Rome, Italy., Carnevale L; Department of Systems Medicine, Infectious Disease Clinic, Tor Vergata University, Rome, Italy., Mulas T; Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy., Coppola L; Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy., Campogiani L; Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy., Sarmati L; Department of Systems Medicine, Infectious Disease Clinic, Tor Vergata University, Rome, Italy.; Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy., Iannetta M; Department of Systems Medicine, Infectious Disease Clinic, Tor Vergata University, Rome, Italy.; Infectious Disease Clinic, Policlinico Tor Vergata, Rome, Italy.

Publikováno v: Frontiers in microbiology [Front Microbiol] 2024 Jun 27; Vol. 15, pp. 1418530. Date of Electronic Publication: 2024 Jun 27 (Print Publication: 2024).

Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis.

Autor: Rindi LV; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy., Zaçe D; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy., Braccialarghe N; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy., Massa B; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy., Barchi V; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy., Iannazzo R; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy., Fato I; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy., De Maria F; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy., Kontogiannis D; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy., Malagnino V; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy.; Infectious Disease Clinic, Policlinico Tor Vergata, Viale Oxford, 81, 00133, Rome, Italy., Sarmati L; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy.; Infectious Disease Clinic, Policlinico Tor Vergata, Viale Oxford, 81, 00133, Rome, Italy., Iannetta M; Department of Systems Medicine, Tor Vergata University, Via Montpellier, 1, 00133, Rome, Italy. marco.iannetta@uniroma2.it.; Infectious Disease Clinic, Policlinico Tor Vergata, Viale Oxford, 81, 00133, Rome, Italy. marco.iannetta@uniroma2.it.

Publikováno v: Drug safety [Drug Saf] 2024 Apr; Vol. 47 (4), pp. 333-354. Date of Electronic Publication: 2024 Feb 07.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.